KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Steris (STE) Payables (2018 - 2025)

Historic Payables for Steris (STE) over the last 8 years, with Q4 2025 value amounting to $285.1 million.

  • Steris' Payables fell 2152.45% to $285.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $285.1 million, marking a year-over-year decrease of 2152.45%. This contributed to the annual value of $405.8 million for FY2025, which is 2017.97% up from last year.
  • Steris' Payables amounted to $285.1 million in Q4 2025, which was down 2152.45% from $308.9 million recorded in Q3 2025.
  • Steris' 5-year Payables high stood at $405.8 million for Q1 2025, and its period low was $157.0 million during Q1 2021.
  • In the last 5 years, Steris' Payables had a median value of $324.1 million in 2023 and averaged $320.2 million.
  • Its Payables has fluctuated over the past 5 years, first skyrocketed by 14914.44% in 2021, then tumbled by 2152.45% in 2025.
  • Over the past 5 years, Steris' Payables (Quarter) stood at $335.0 million in 2021, then fell by 9.71% to $302.5 million in 2022, then increased by 17.41% to $355.2 million in 2023, then rose by 2.29% to $363.3 million in 2024, then decreased by 21.52% to $285.1 million in 2025.
  • Its last three reported values are $285.1 million in Q4 2025, $308.9 million for Q3 2025, and $300.9 million during Q2 2025.